Sunday, February 17, 2019

DrFormulas' Best Probiotics for Women & Men | Nexabiotic Multi Probiotic with Saccharomyces Boulardii, Lactobacillus Acidophilus, B. infantis, Prebiotic 60 Capsules (Not Pearls)

Bifidobacteria

What is it?
Bifidobacteria are a group of bacteria that normally live in the intestines. They can be grown outside the body and then they can be taken orally as medicine.

Bifidobacteria are commonly used to treat diarrhea, constipation, and intestinal disorder called irritable bowel syndrome; to prevent the common cold and the flu, and many other conditions. However, there is no good scientific evidence to support many of these uses.

How effective is it?
Natural Medicines Comprehensive Database classifies the effectiveness, based on scientific evidence, according to the following scale: Effective, Probably Effective, Possibly Effective, Possibly Ineffective, Probably Ineffective, Ineffective, and Insufficient Evidence for Make a Determination.



DrFormulas' Best Probiotics for Women & Men | Nexabiotic Multi Probiotic with Saccharomyces Boulardii, Lactobacillus Acidophilus, B. infantis, Prebiotic 60 Capsules (Not Pearls)
DrFormulas' Best Probiotics for Women & Men | Nexabiotic Multi Probiotic with Saccharomyces Boulardii, Lactobacillus Acidophilus, B. infantis, Prebiotic 60 Capsules (Not Pearls)




The classification of efficacy for this product is as follows:

Possibly effective for ...
  • Constipation Research shows that the intake of bifidobacteria can decrease bowel movements in approximately 2-4 stools per week in people with constipation.
  • Infection by Helicobacter pylori (H. pylori) The intake of bifidobacteria and lactobacillus together with a standard treatment of H. pylori helps to fight H. pylori infections by approximately twice as much, as does treatment only for H. pylori. It can also reduce side effects caused by treatment for H. pylori.
  • Irritable bowel syndrome (IBS) Most research shows that the intake of bifidobacteria for 4-8 weeks can reduce the symptoms of IBS, such as stomach pain, bloating, and difficulty moving the bowels. It could also reduce symptoms, such as anxiety and depression, in people with SCI. However, there is some contradictory research.
  • A complication following surgery for ulcerative colitis called pouchitis The intake of a combination of bifidobacteria, lactobacilli, and streptococci seems to help prevent pouchitis after surgery for ulcerative colitis.
  • Respiratory tract infections Research shows that the use of probiotics containing bifidobacteria could help prevent respiratory tract infections, such as the common cold in people without any other health complication, including children of primary and secondary age. However, intake of bifidobacteria does not appear to reduce the risk of respiratory tract infections in hospitalized children and adolescents.
  • Diarrhea in babies (retroviral diarrhea) The administration of bifidobacteria in babies with retroviral diarrhea can shorten the duration of diarrhea by approximately one day.
  • Traveler's Diarrhea The intake of bifidobacteria helps prevent traveler's diarrhea when used with other probiotics such as lactobacillus or streptococcus.
  • Ulcerative colitis Other research shows that the intake of probiotics containing bifidobacteria along with lactobacilli and streptococci can help increase the rate of remission by approximately twice as many in people with active ulcerative colitis. However, other research shows that bifidobacteria does not help prevent remission.

Possibly ineffective for ...
  • Diarrhea due to an infection with the bacteria. Clostridium difficile. Most research shows that the intake of bifidobacteria together with another probiotic does not prevent diarrhea caused by Clostridium difficile infection.
  • Mortality in premature babies. Adding bifidobacteria in formula does not reduce the risk of death in premature babies.
  • Child development. The administration of infant formula containing bifidobacteria and lactobacilli does not stimulate growth in babies.
  • Damage to the intestinal tract in premature babies (necrotising enterocolitis, NEC). Research shows that the administration of bifidobacteria in premature babies does not prevent necrotizing enterocolitis or death from any cause.
  • Infection in the blood (septicemia). Adding bifidobacteria in infant formula does not prevent septicemia in premature babies.
  • Weightloss. The intake of bifidobacteria for 6 months does not decrease the weight loss in overweight or obese people.

Insufficient evidence to make a determination to ...
  • Diarrhea caused by antibiotics. Research shows that the intake of bifidobacteria together with antibiotics can reduce the chance of having diarrhea by 45%. But there are certain contradictory results. It is possible that bifidobacteria prevent diarrhea caused by certain antibiotics, but not all. In addition, bifidobacteria may work best when used in certain combinations with lactobacilli or streptococci. However, not all combinations seem to work.
  • Itching and inflammation of the skin (eczema). Some research shows that the administration of bifidobacteria in babies can help to treat eczema, although there are contradictory results. Other research shows that the administration of bifidobacteria plus lactobacillus in pregnant women during the last 2 months of pregnancy and then administration in infants during the first 2 months of life can help PREVENT eczema. However, there are certain contradictory results. The administration of bifidobacteria and lactobacilli only in babies at risk during the first 6 months of life does not prevent eczema.
  • Celiac Disease. Preliminary research shows that the intake of bifidobacteria as part of a gluten-free diet does not decrease stomach and intestinal symptoms compared to a diet alone in children with recently diagnosed celiac disease.
  • Infections related to chemotherapeutic treatment. Preliminary research shows that ingestion of bifidobacteria with lactobacilli or bifidobacteria with lactobacilli and with enterococci does not prevent fungal infections in people with leukemia and undergoing chemotherapy.
  • Diabetes. Preliminary research shows that the intake of bifidobacteria along with lactobacilli helps decreases fasting sugar levels and insulin levels in people with diabetes in pregnancy. However, this combination does not help to lower cholesterol or other levels of fats in the blood in people with this condition.
  • Muscle pain due to physical exercise. Preliminary research shows that the intake of bifidobacteria and streptococci does not reduce muscle pain caused by lifting weights. However, range of motion does not appear during follow-up exercises despite muscle pain.
  • High cholesterol. Preliminary research shows that the intake of a milk containing bifidobacteria and lactobacilli can lower the "bad" low-density lipoprotein cholesterol in people with slightly high cholesterol. However, "good" high-density lipoprotein cholesterol also seems to decrease.
  • Allergy to the pollen of the Japanese cedar. Some research shows that the intake of bifidobacteria during the pollination season reduces the symptoms of rhinitis and irritated eyes due to the allergy caused by Japanese cedar pollen. However, there are certain contradictory results. Bifidobacteria do not seem to reduce sneezing and sore throat symptoms associated with allergy caused by Japanese cedar pollen.
  • Prevention of infections after exposure to radiation. Preliminary research shows that bifidobacteria resistant to antibiotics can help improve short-term survival in the treatment of radiation sickness. In combination with antibiotics, bifidobacteria appear to help prevent the growth of dangerous bacteria and a serious infection.
  • Arthritis. Preliminary research shows that the intake of bifidobacteria and lactobacilli does not reduce the symptoms of severity or decrease joint pain in people with moderate to severe arthritis.

  1. Aging.
  2. Pain in the breasts, possibly due to an infection (mastitis).
  3. Cancer.
  4. Lactose intolerance.
  5. Liver problems
  6. Lyme's desease.
  7. Mumps.
  8. Replacement of beneficial bacteria eliminated in diarrhea.
  9. Digestive disorders
  10. Other conditions.
More evidence is needed to evaluate the efficacy of bifidobacteria for these uses.

How does it work?

Bifidobacteria belong to a group of bacteria called lactic acid bacteria. Lactic acid bacteria are found in fermented foods such as yogurt and cheese. Bifidobacteria are used in the treatment with so-called "probiotics", the opposite of antibiotics. They are considered "friendly" bacteria and are taken to grow and multiply in areas of the body where they would normally grow. The human body has a normal bacterial flora that is responsible for several jobs. They break food, help the body absorb nutrients and prevent overgrowth of "bad" bacteria. Probiotics, such as bifidobacteria, are commonly used in cases where a disease occurs or may occur due to the death of the normal bacterial flora. For example, treatment with antibiotics can destroy the bacteria that cause the diseases, but also kill the other bacteria in the gastrointestinal (GI) tract and in the urinary tract. The theory is that taking probiotic bifidobacteria during treatment with antibiotics can prevent or minimize the death of good bacteria and prevent the overgrowth of bad bacteria.

Is there concern for the safety of its use?
Bifidobacteria are PROBABLY SAFE for adults and children when properly ingested. In some people, treatment with bifidobacteria may cause stomach and intestinal discomfort and cause diarrhea, bloating and gas.

Special warnings and precautions:
Pregnancy and breast-feeding: There is not enough reliable information on whether the intake of bifidobacteria is safe if you are pregnant or breast-feeding. Be cautious and avoid its use.

Weakness of the immune system: There is some concern that "probiotics" could grow too well in people with a weak immune system and produce infections. Although this has not occurred specifically with bifidobacteria, there have been some cases involving the participation of other probiotic species such as Lactobacillus. If you have a weakened immune system (for example, if you have HIV / AIDS or are being treated for cancer), check with your doctor before using bifidobacteria.

Obstruction in the intestines: Two cases of infection in the blood were reported in infants who were given bifidobacteria probiotics. In both cases, the babies have had stomach surgery. It is believed that blood infections are caused by an intestinal obstruction caused by stomach surgeries, which allows the passage of bifidobacteria through the bloodstream. In one case, the intake of bifidobacteria after curing the intestinal obstruction did not cause another infection of the blood. Therefore, the risk of infections in most babies who ingest bifidobacteria is not a concern. However, bifidobacteria should be used with caution or avoided in babies with stomach or intestinal obstruction.

Are there interactions with medications?
  • Moderate
  • Be careful with this combination
  • Antibiotics
  • Antibiotics are used to reduce harmful bacteria in the body. Antibiotics can also reduce friendly bacteria in the body. Bifidobacteria are a type of friendly bacteria. Taking antibiotics together with bifidobacteria could reduce the efficacy of bifidobacteria. To avoid this interaction, take the bifidobacterial products at least two hours before or after the antibiotics.

  • Are there interactions with herbs and supplements?
  • There is no known interaction with herbs and supplements.
  • Are there interactions with food?
  • No interaction with food is known.
  • What dose is used?
  • The following doses have been studied in scientific research:

ADULTS
ORALLY:
Constipation: 100 million to 20 billion units of bifidobacteria forming colonies were used. In most cases, bifidobacteria are ingested daily for 1-4 weeks. In some cases, 5-60 billion units of bifidobacteria and lactobacilli forming colonies were ingested every day for 1 month.
Irritable bowel syndrome (IBS): To improve stomach and intestinal symptoms, 100 million to one billion units of colony-forming bifidobacteria were used every day for 4-8 weeks. In addition, 5 billion units of bifidobacteria, lactobacilli and colony-forming streptococci were used twice a day for 4 weeks. To improve depression and anxiety in people with SCI, 10 million units of colony-forming bifidobacteria were used once per day for 6 weeks.
Respiratory tract infections: 3 billion units of colony-forming bifidobacteria were used every day for 6 weeks.
A complication after surgery for ulcerative colitis called pouchitis: a dose of up to 3 trillion units of bifodobacteria, lactobacilli, and colony-forming streptococci was used once a day for up to 12 months.
Treatment by Helicobacter pylori: 5 billion units of bifidobacteria and lactobacilli forming colonies were used, every day for a week during the treatment of H. pylori, followed by one more week of treatment.
Ulcerative colitis: To increase remission, 3 grams, equivalent to 900 billion units of lactobacilli, bifidobacteria and colony-forming streptococci, were used once or twice a day.

CHILDREN
ORALLY:
Constipation: 1-100 billion units of colony-forming bifidobacteria were used every day for 4 weeks in children aged 3-16 years.
Respiratory tract infections: 10 billion units of colony-forming bifidobacteria were used every day for 4 weeks.
Respiratory tract infections: 2.10 units of a combination of bifidobacteria and lactobacilli forming colonies, 2 times per day in children aged 3-13 years were used.
Diarrhea in babies (retroviral diarrhea): Bifidobacteria were used together with streptococci in children up to 3 years of age. In addition, bifidobacteria and lactobacilli were used twice a day for 3 days.
Ulcerative colitis Up to 1.8 billion units of bifidobacteria, lactobacilli, and colony-forming streptococci were used every day for up to 1 year in children 1-16 years of age.

Other names
B. Bifidum, B. Brief, B. Infantis, B. lactis, B. Longum, Bifido, Bifido Bacterium Longum, Bifidobacteria, Bifidobactéries, Bifidobacterium, Bifidobacterium adolescentis; Bifidobacterium animalis, Bifidobacterium bifidum; Bifidobacterium breve; Bifidobacterium infantis; Bifidobacterium lactis; Bifidobacterium longum, Bifidum, Bifidus, Bifidus Brevis, Bifidus Infantis, Bifidus Longum, Bifidobacteria Bifidus, Lactobacillus Bifidus, L. Bifidus, Probiotic, Probiotique.